Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
India · Delayed Price · Currency is INR 1,198.00
+21.25 (1.81%)
At close: Oct 1, 2026
Symbiotec Pharmalab Market Cap
Symbiotec Pharmalab has a market cap or net worth of 76.98 billion as of October 2, 2026.
Market Cap
76.98B
Enterprise Value
80.79B
Revenue
8.84B
Ranking
n/a
PE Ratio
79.95
Stock Price
1,198.00
ChartMarket Cap Chart
Since September 1, 2026, Symbiotec Pharmalab's market cap has increased from 70.53B to 76.98B, an increase of 9.14%. That is a compound annual growth rate of 189.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 76.98B | 1.81% |
| Sep 30, 2026 | 75.61B | 2.84% |
| Sep 29, 2026 | 73.52B | 8.38% |
| Sep 28, 2026 | 67.84B | 5.22% |
| Sep 25, 2026 | 64.47B | -2.02% |
| Sep 24, 2026 | 65.80B | -3.57% |
| Sep 23, 2026 | 68.24B | -5.25% |
| Sep 22, 2026 | 72.02B | -3.04% |
| Sep 21, 2026 | 74.28B | 5.57% |
| Sep 18, 2026 | 70.37B | 4.73% |
| Sep 17, 2026 | 67.19B | 0.27% |
| Sep 16, 2026 | 67.01B | -3.45% |
| Sep 15, 2026 | 69.40B | -4.71% |
| Sep 11, 2026 | 72.83B | -0.48% |
| Sep 10, 2026 | 73.18B | 0.46% |
| Sep 9, 2026 | 72.85B | 3.62% |
| Sep 8, 2026 | 70.30B | -0.42% |
| Sep 7, 2026 | 70.60B | 1.90% |
| Sep 4, 2026 | 69.28B | 0.13% |
| Sep 3, 2026 | 69.19B | -1.46% |
| Sep 2, 2026 | 70.22B | -0.45% |
| Sep 1, 2026 | 70.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 275.80B |
| Shilpa Medicare | 208.03B |
| Suven Life Sciences | 87.17B |
| IOL Chemicals and Pharmaceuticals | 61.48B |
| Gujarat Themis Biosyn | 49.76B |
| NGL Fine-Chem | 17.97B |
| Bajaj HealthCare | 10.89B |
| Shree Ganesh Remedies | 8.81B |